/Investor DB

Ambit Health Ventures — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

Osteoboostosteoboost.comin𝕏Series A · Dec 2020 · $3M✓ verified

Osteoboost is an FDA-cleared, drug-free prescription device that uses precision vibration therapy to slow bone density and strength loss in postmenopausal women with osteopenia.

Digital HealthFemTechMedical Devices

Dan Burnett(Co-Founder)inMichael Jaasma(Chief Scientific Officer and Co-Founder)inShane Mangrum(Co-Founder)inLaura Yecies(Chief Executive Officer & President)inPamela M. Peeke(Chief Medical Officer)in

Co-investorsEsplanade VenturesBand of AngelsGolden SeedsGood Growth CapitalHealthtech CapitalNew York Angels+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.